IL6 and breast cancer: HER2-overexpressing BC cells show enhanced IL-1α production, which acts as a proinflammatory signal to activate additional signaling sequences (such as IL-6) and trigger the STAT3 and NF-κB pathways for generating and maintaining chronic inflammation and cancer stem cells (CSCs), thus promoting tumor occurrence and development17.